Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WholePeople.com, Amrion Web Business Merged With Gaiam.com

This article was originally published in The Tan Sheet

Executive Summary

A new plan to restructure Amrion will bring profitability to the struggling dietary supplement direct marketer "by the end of fiscal year 2001," parent company Whole Foods Market predicted.

You may also be interested in...



Whole Foods' Amrion Business Future Weighed

Amrion may be on the selling block due to a soft supplements market and unfavorable investment results. The supplement manufacturer and direct marketer's parent company, Whole Foods Market, retained the investment banking firm Dain Raushcer Wessels to help it consider "strategic alternatives."

Whole Foods' Amrion Business Future Weighed

Amrion may be on the selling block due to a soft supplements market and unfavorable investment results. The supplement manufacturer and direct marketer's parent company, Whole Foods Market, retained the investment banking firm Dain Raushcer Wessels to help it consider "strategic alternatives."

Whole Foods' Amrion Business Future Weighed

Amrion may be on the selling block due to a soft supplements market and unfavorable investment results. The supplement manufacturer and direct marketer's parent company, Whole Foods Market, retained the investment banking firm Dain Raushcer Wessels to help it consider "strategic alternatives."

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091364

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel